Lithium Carbonate Tablet, Extended Release
Product Images NDC 0054-0021

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 0054-0021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fpl-bl-300mg-100tab-05.jpg (Fpl Bl 300mg 100tab 05)

This is the label of Lithium Carbonate Extended-release tablets. It contains usages instructions, dosage information, and storage conditions. The tablets come in a tight container that is child-resistant. It should be stored at room temperature and protected from moisture. The manufacturer is West-Ward Pharmaceuticals Corp. There is a warning included in the package insert, and each tablet contains 300 mg lithium carbonate USP. There is also a unique identifier NDC 0054-0021-25. The last line includes a code 10002521/05, and the other text that includes symbols cannot be identified.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.